FDA (Drugs) recall action 69633
The FDA (Drugs) publishes a recall like this one as 4 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 4 pages.
Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Vann Healthcare Services is recalling Hydroxyprogesterone Caproate vials because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility.
Vann Healthcare Services is recalling 410 epinephrine syringes because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to assure sterility.
Vann Healthcare Services is recalling Lidocaine 4% syringes because an FDA inspection found deficiencies in the facility's ability to assure sterility.
Vann Healthcare Pharmacy is recalling Tri-mix #4 vials because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility.